Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02181114 · ClinicalTrials.gov registry record · NA

Your Path to Transplant: A Randomized Control Trial of A Tailored Computer Education Intervention for Living Donor Kidney Transplant

A NA study, sponsored by The Methodist Hospital Research Institute.

Completed
Registry status
NA
Development phase
815
Enrollment target

NCT02181114: Completed NA study, sponsored by The Methodist Hospital Research Institute.

NCT02181114 is a NA study that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 815 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02181114, a NA study, has completed, sponsored by The Methodist Hospital Research Institute.

COMPLETED
Registry status
NA
Development phase
815 participants
Enrollment target

Study Summary

Because of the deceased donor organ shortage, more kidney patients are considering whether to receive kidneys from family and friends, a process called living donor kidney transplantation (LDKT). Although Blacks are 3.4 times more likely to develop end stage renal disease, they are less likely to receive LDKTs. To address this disparity, this randomized controlled trial will assess whether Black and White transplant patients' knowledge and receipt of LDKTs can be increased when they receive access to the Your Path to Transplant computerized Expert System (YPT). This trial will also examine how other known patient, family, and healthcare system barriers to LDKT impact YPT's effectiveness. Nine hundred (900) Black,White and Hispanic ESRD patients presenting for transplant medical evaluation at University of California-Los Angeles Kidney and Pancreas Transplant Program (UCLA-KPTP) in Los Angeles, California will be stratified by race and randomly assigned to one of two education conditions (YPT vs. Usual Care Education). As they undergo transplant evaluation, patients in the YPT condition will receive individually-tailored feedback reports, coaching, and socioeconomic resource guidance associated with reducing barriers to access to LDKT. Control patients will receive usual care transplant education provided by UCLA-KPTP. Changes in knowledge, readiness to pursue LDKT, pros/cons to LDKT, and self-efficacy will be assessed at four time points: prior to presenting at the transplant center (baseline), during transplant evaluation (approximately 2 months post-baseline), and 4- and 8-months post-baseline. Completion of transplant evaluation and receipt of LDKTs will be assessed 18-months post-baseline. At the conclusion of the study, we will have developed an innovative and cost-effective YPT Computerized Expert System that could be utilized to tailor LDKT discussion and education in different medical settings based on the needs of individual patients of different races.

Primary Outcome

Using validated measures, patients will be asked how ready they are to get a DDKT by reporting whether they are "not considering getting a DDKT in the next six months" (Precontemplation), "considering getting a DDKT in the next six months" (Contemplation), "preparing to get a DDKT in the next 30 days" (Preparation), "undergoing evaluation to get a DDKT" (Action) or "listed and waiting to get a DDKT" (Maintenance). Patients will also be asked how ready they are to pursue LDKT and to rate whether

Interventions

  • BEHAVIORAL Expert System Coaching

Trial Details

FieldValue
Enrollment Target 815 participants
Start Date 2014-05
Est. Completion 2017-12
Phase NA

What the finished NCT02181114 record still lists

NCT02181114 is an interventional study that assigns participants to a tested intervention. The registered 815 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% lower).

The record links to 0 conditions, and to 1 intervention - of which Expert System Coaching is the first listed.

NCT02181114 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02181114 about?

NCT02181114 is a clinical study titled "Your Path to Transplant: A Randomized Control Trial of A Tailored Computer Education Intervention for Living Donor Kidney Transplant". Because of the deceased donor organ shortage, more kidney patients are considering whether to receive kidneys from family and friends, a process called living donor kidney transplantation (LDKT). Although Blacks are 3.4 times more likely to develop end stage renal disease, they are less likely to re...

What is the current status of trial NCT02181114?

This trial is currently completed. It is a NA study. The enrollment target is 815 participants. The study started on 2014-05. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02181114?

The interventions under investigation include: Expert System Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT02181114?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02181114's enrollment target sits among peer trials

815 134th of 2000 higher than 1,867 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07218029 · 815 participants · Phase 3

    A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

  • NCT04846959 · 818 participants

    Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

  • NCT04028687 · 820 participants

    MDR - PMCF Study for Taperloc Complete Stems

  • NCT04613440 · 820 participants · NA

    FaCT Trial (Facilitated Cascade Testing Trial)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02181114, the US trial registry maintained by the National Library of Medicine. NCT02181114 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.